 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              Mr. Rajiv Gandhi, CEO and Managing Director, Hester Biosciences Ltd
"There are lot of positives in this Budget. FM has focused on economic reforms and on reviving the investment cycle in the country. Setting up Atal Innovation Mission (AIM) and earmarking a budget of Rs. 150 crore will foster a culture of innovation, R&D and scientific research in India. Launching three new National Institutes of Pharmaceutical Education and Research in Maharashtra, Rajasthan, and Chhattisgarh will also give a boost to the R&D in pharmaceutical sector. Proposal to reduce corporate tax from 30% to 25% and rationalization of exemptions along with commitment to implement GST from April, 2016 are welcome steps. All in all, it is a balanced budget. The Finance minister has delivered on the expectations."